2019 annual financial data
Cogent Biosciences 2019 Net margin
Direct answer
Net margin was -134.55%.
Operating income was -32,178,000 USD and net income was -30,273,000 USD.
Operating cash flow was -41,514,000 USD.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,499,000 USD
- Operating income
- -32,178,000 USD
- Net income
- -30,273,000 USD
- Operating cash flow
- -41,514,000 USD